Mobility paves Samsung’s silver path
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
The researchers believe their therapy would not only prevent Covid-19 from affecting a person’s lungs but will also address lung injuries already inflicted by the virus - V Raju
Shiv Nadar University on Tuesday has said it has discovered a set of New Chemical Entities (NCEs) with the ability to cure Acute Respiratory Distress Syndrome (ARDS) or Acute Lung Injury (ALI) induced by Covid-19 (SARS-CoV-2) and Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), which are also caused by coronaviruses.
A team of researchers led by Dr Subhabrata Sen, Professor, Department of Chemistry, Shiv Nadar University, along with his collaborator Professor Ralf Jockers, Institut Cochin (INSERM, CNRS, Université de Paris, France), were involved in the project.
A press statement from the university said the two-fold strategy devised by the research team involved (a) application of the NCEs to inhibit attachment, entry and infection of the new SARS-CoV-2 through a known target on the virus; and (b) co-administration of a known drug (that modulates a set of hormonal receptors in humans) and these NCEs to attenuate ARDS caused by SARS-CoV-2.
The researchers believe their therapy would not only prevent Covid-19 from affecting a person’s lungs but will also address lung injuries already inflicted by the virus, in cases the ventilators are either not proving effective or are not available altogether, bringing much relief to Covid-19 patients suffering from ARDS.
Dr Subhabrata Sen said, “We hope our therapeutic approach will unravel solutions against maladies associated with acute respiratory distress syndrome. Our aim is to conclude the preclinical studies by the end of this year, post which the new compound will potentially be ready for the next stage of development along with human trials.”
Dr Rupamanjari Ghosh, Vice-Chancellor, Shiv Nadar University, said, “Covid-19 has caused catastrophic effects globally — affecting lives and livelihoods. At the Shiv Nadar University, it is our constant endeavour to work towards addressing issues of local and global importance by investing in relevant research. This particular research holds out the promise for a drug that can combat Covid-19, SARS and MERS — this is highly commendable. In this hour of a global crisis, our global team of researchers with unique core competencies has come together in solidarity — my heartiest congratulations to the group led by Prof. Sen.”
Professor Ralf Jockers, a molecular biologist from Institut Cochin, said, “I am excited about the project that we are currently running together with Prof. Sen on novel treatments for Covid-19 and I am hopeful that we can make a significant contribution to solving the challenges of this pandemic.”
The researchers have filed a provisional patent in India to protect the new chemical entities. The novel molecule in discovery is being moved to the next stage of checking where its efficacy will be tested on animals.
The discovery has come out of months of research conceptualising small molecule modulators of a set of hormonal receptors in humans and how they are connected with potential receptors in the lungs that act as the entry of SARS-CoV-2, SARS and MERS in the human host.
Additionally, the researchers looked into the pathophysiological condition of lungs during respiratory failure. This included extensive investigations of lung specimens from patients who were retrospectively found to have Covid-19. Using these data, the researchers designed the project that helps in attenuating acute respiratory distress.
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
Antrix should adopt a different tactic than merely fighting over jurisdiction: Experts
Invest in relationships, enterprise, behaviour, effort and learning
From different types of osmoses to new membranes, researchers have come up with ways of drawing water
What filters should you apply when mining for under-the-radar small-cap stocks? Read on to find more
High valuation, intensely competitive landscape and small cap nature of the stock are key risks.
Amid choppiness, the benchmark indices slipped marginally; approach the week with caution
SBI Cards (₹1,032.7): Witnesses fresh breakoutBetween September and December last year, the stock of SBI Cards ...
That weekend came the news that Champa’s elder daughter was engaged, the proof arriving in the form of Jaimini ...
“Amma,” Divya yelled from the bathroom. “There’s something in my teeth.”Balakrishnan and Veena froze and ...
What makes the new crop of young Indian cricketers such game-changing winners? Over and above their talent, ...
For their dead, Parsis practise a 3,000-year-old system where corpses are excarnated in the Tower of Silence, ...
WPP agency Wunderman Thompson has launched its annual Future 100 report, lifting the lid on trends shaping the ...
Paneer, once alien to the South, has found a lucrative market in Chennai
Social media influencers are flipping the rules by first getting followers and then launching products and ...
The Flipkart kids playing adults are back — this time to push the home grown e-commerce marketplace’s grocery ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor